PSORIASIS
HealthValue.
Four key therapeutic breakthroughs thanks to monoclonals and fusion proteins
An anti CD11a  (cell adhesion factor) monoclonal antibody : efalizumab
A fusion protein between the extra cellular  portion of LFA3, and the Fc domain of a human IgG1 : alefacept
Back to home page
Anti TNF drugs :
- an anti TNF monoclonal antibody : infliximab
- an anti TNF fusion protein : etanercept
PSORIASIS

Psoriasis main page
Psoriasis mechanism
Alefacept
Efalizumab
Etanercept, anti TNF
Infliximab, anti TNF
Certolizumab
changer de langue